Personalized survivorship care: Routine breast cancer risk assessment in the gynecologic oncology clinic

Gynecologic and breast cancers share several risk factors. Breast cancer risk assessment tools can identify those at elevated risk and allow for enhanced breast surveillance and chemoprevention, however such tools are underutilized. We aim to evaluate the use of routine breast cancer risk assessment...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Gynecologic oncology 2024-04, Vol.183, p.47-52
Hauptverfasser: Ahsan, Muhammad Danyal, Webster, Emily M., Wolfe, Isabel A., McGonigle, Rylee, Brewer, Jesse T., Chandler, Isabelle R., Weiss, Jessica M., Enriquez, Allan, Cantillo, Evelyn, Holcomb, Kevin, Chapman-Davis, Eloise, Blank, Stephanie V., Sharaf, Ravi N., Frey, Melissa K.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Gynecologic and breast cancers share several risk factors. Breast cancer risk assessment tools can identify those at elevated risk and allow for enhanced breast surveillance and chemoprevention, however such tools are underutilized. We aim to evaluate the use of routine breast cancer risk assessment in a gynecologic oncology clinic. A patient-facing web-based tool was used to collect personal and family history and run four validated breast cancer risk assessment models (Tyrer-Cuzick (TC), Gail, BRCAPRO, and Claus) in a gynecologic oncology clinic. We evaluated completion of the tools and identification of patients at elevated risk for breast cancer using the four validated models. A total of 99 patients were included in this analysis. The BRCAPRO model had the highest completion rate (84.8%), followed by the TC model (74.7%), Gail model (74.7%), and the Claus model (52.1%). The TC model identified 21.6% of patients completing the model as having ≥20% lifetime risk of breast cancer, compared to 6.8% by the Gail model, and 0% for both the BRCAPRO and Claus models. The Gail model identified 52.5% of patients as having ≥1.67% 5-year risk of breast cancer. Among patients identified as high-risk for breast cancer and eligible for screening, 9/9 (100%) were referred to a high-risk breast clinic. Among patients that completed the TC breast cancer risk assessment in a gynecologic oncology clinic, approximately 1 in 5 were identified to be at significantly elevated lifetime risk for breast cancer. The gynecologic oncologist's office might offer a convenient and feasible setting to incorporate this risk assessment into routine patient care, as gynecologic oncologists often have long-term patient relationships and participate in survivorship care. •21.6% of patients completing the Tyrer-Cuzick model had ≥20% lifetime risk of breast cancer.•The Tyrer-Cuzick model was more sensitive at identifying high-risk patients compared to Gail, Claus, and BRCAPRO models.•52.5% of those who completed the Gail model had ≥1.67% 5-year risk of breast cancer, and thus eligible for chemoprophylaxis.
ISSN:0090-8258
1095-6859
1095-6859
DOI:10.1016/j.ygyno.2024.03.004